Evidence map›Paper›PMID 35888179›Full record

ArticleLife (Basel, Switzerland)2022

Medullary Thyroid Carcinoma and Associated Endocrinopathies in Slovenia from 1995 to 2021.

Sara Milicevic, Mateja Krajc, Ana Blatnik, Barbara Peric

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Life (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Sara MilicevicInstitute of Oncology Ljubljana, Zaloska 2, 1000 Ljubljana, Slovenia.
Mateja KrajcInstitute of Oncology Ljubljana, Zaloska 2, 1000 Ljubljana, Slovenia.ORCID 0000-0003-0605-2592
Ana BlatnikInstitute of Oncology Ljubljana, Zaloska 2, 1000 Ljubljana, Slovenia.
Barbara PericInstitute of Oncology Ljubljana, Zaloska 2, 1000 Ljubljana, Slovenia.
University of Ljubljana · SIInstitute of Oncology Ljubljana · SI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMedullary thyroid cancer (MTC) is a rare endocrine tumour that is sporadic in 75% of cases and occurs as a part of inherited cancer syndromes in approximately 25% of cases. The aim of this study was to determine the frequency and type of

methodsA retrospective analysis of medical records of 266 MTC patients and their relatives seen in a tertiary centre between 1995 and 2021 was performed. Sequence analysis of exons 10, 11, 13, 14, 15, and 16 of the

resultsGermline PVs in the

conclusionsAnalysis of prospectively collected MTC cases during a 27-year period revealed that 21.6% of Slovenian patients are

Indexed as

medullary thyroid carcinomamultiple endocrine neoplasiapheochromocytomaprimary hyperparathyroidismRET pathogenic variant

Identifiers

PMID35888179
PMCPMC9320156
OpenAlexW4286433633

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.